Evidence map›Paper›PMID 33810254›Full record

ReviewMolecules (Basel, Switzerland)2021

Overview of Syntheses and Molecular-Design Strategies for Tetrazine-Based Fluorogenic Probes.

Sang-Kee Choi, Jonghoon Kim, Eunha Kim

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Synthesis and Luminescent Properties ofMolecules (Basel, Switzerland) · 2022
    Article
  15. Novel ConjugatedMolecules (Basel, Switzerland) · 2022
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sang-Kee ChoiDepartment of Molecular Science and Technology, Ajou University, Suwon 16499, Korea.
Jonghoon KimDepartment of Chemistry, Soongsil University, Seoul 06978, Korea.ORCID 0000-0003-4951-5497
Eunha KimDepartment of Molecular Science and Technology, Ajou University, Suwon 16499, Korea.ORCID 0000-0002-0766-696X

Funding

KRIBB Research Initiative Program KGM9952011National Research Foundation of Korea 2019M3D1A1078941National Research Foundation of Korea 2019R1A6A1A11051471National Research Foundation of Korea 2020R1C1C1010044
6 · The paper itself

Abstract

Various bioorthogonal chemistries have been used for fluorescent imaging owing to the advantageous reactions they employ. Recent advances in bioorthogonal chemistry have revolutionized labeling strategies for fluorescence imaging, with inverse electron demand Diels-Alder (iEDDA) reactions in particular attracting recent attention owing to their fast kinetics and excellent specificity. One of the most interesting features of the iEDDA labeling strategy is that tetrazine-functionalized dyes are known to act as fluorogenic probes. In this review, we will focus on the synthesis, molecular-design strategies, and bioimaging applications of tetrazine-functionalized fluorogenic probes. Traditional Pinner reaction and "Pinner-like" reactions for tetrazine synthesis are discussed here, as well as metal-catalyzed C-C bond formations with convenient tetrazine intermediates and the fabrication of tetrazine-conjugated fluorophores. In addition, four different quenching mechanisms for tetrazine-modified fluorophores are presented.

Indexed as

FluorescenceFluorescent DyesHeterocyclic Compounds, 1-RingOptical ImagingKineticsFluorescent DyesHeterocyclic Compounds, 1-Ringbioimagingclick chemistryfluorogenictetrazine

Identifiers

PMID33810254
PMCPMC8037913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.